December 17, 2017 2:30 AM ET

Biotechnology

Company Overview of T2 Biosystems, Inc.

Company Overview

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company also offers T2Dx, a bench-top instrument for sepsis, Lyme disease, and other applications, as well as T2Candida panel for the detection of candida species in human whole blood specimens. In addition, it is developing T2Bacteria, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2Lyme for t...

101 Hartwell Avenue

Lexington, MA 02421

United States

Founded in 2006

178 Employees

Phone:

781-761-4646

Fax:

781-357-3080

Key Executives for T2 Biosystems, Inc.

CEO, President & Director
Age: 57
Total Annual Compensation: $425.5K
Chief Scientific Officer
Age: 38
Total Annual Compensation: $334.6K
Compensation as of Fiscal Year 2016.

T2 Biosystems, Inc. Key Developments

T2 Biosystems, Inc. Presents at Global Mizuho Investor Conference 2017, Dec-04-2017

T2 Biosystems, Inc. Presents at Global Mizuho Investor Conference 2017, Dec-04-2017 . Venue: Lotte New York Palace Hotel, 455 Madison Avenue (Between E.50 & E.51 streets), New York, New York, United States. Speakers: Darlene M. Deptula-Hicks, Chief Financial Officer and Senior Vice President, John P. McDonough, CEO, President & Director.

T2 Biosystems, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017; Provides Earnings Guidance for the Fourth Quarter of 2017

T2 Biosystems, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, the company reported total revenue of $1,108,000 against $1,084,000 a year ago. Loss from operations was $12,437,000 against $11,945,000 a year ago. Net loss and comprehensive loss was $14,076,000 or $0.45 basic and diluted per share against $12,783,000 or $0.51 basic and diluted per share a year ago. For the nine months, the company reported total revenue of $3,005,000 against $3,171,000 a year ago. Loss from operations was $39,486,000 against $37,972,000 a year ago. Net loss and comprehensive loss was $44,234,000 or $1.43 basic and diluted per share against $40,255,000 or $1.64 basic and diluted per share a year ago. For the fourth quarter, total revenue is expected to be in the range of $1.1 million to $1.3 million. Operating expenses, excluding cost of product revenue, for the fourth quarter are projected to be in the range of $11.4 million to $11.8 million.

T2 Biosystems, Inc. Presents at 11th Annual Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-09-2017

T2 Biosystems, Inc. Presents at 11th Annual Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-09-2017 . Venue: Westin New York Grand Central Hotel, 212 East 42nd Street, New York, New York, United States. Speakers: Darlene M. Deptula-Hicks, Chief Financial Officer and Senior Vice President, John P. McDonough, CEO, President & Director.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact T2 Biosystems, Inc., please visit www.t2biosystems.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.